Education
About Us
Working with TipRanks
Follow Us
China Shineway Pharmaceutical Group Limited (HK:2877)
:2877
RESEARCH TOOLSreports
Total Valuation
China Shineway Pharmaceutical Group Limited has a market cap or net worth of HK$5.45B. The enterprise value is ―.
Market CapHK$5.45B
Enterprise Value―
Share Statistics
China Shineway Pharmaceutical Group Limited has 827,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding827,000,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
China Shineway Pharmaceutical Group Limited’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 7.79%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)7.79%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee1.17M
Profits Per Employee355.81K
Employee Count3,220
Asset Turnover0.38
Inventory Turnover1.16
Valuation Ratios
The current PE Ratio of China Shineway Pharmaceutical Group Limited is 8.17. China Shineway Pharmaceutical Group Limited’s PEG ratio is -0.25.
PE Ratio8.17
PS Ratio0.00
PB Ratio0.68
Price to Fair Value0.92
Price to FCF10.22
Price to Operating Cash Flow8.95
PEG Ratio-0.25
Income Statement
In the last 12 months, China Shineway Pharmaceutical Group Limited had revenue of 3.78B and earned 840.05M in profits. Earnings per share was 1.11.
Revenue3.78B
Gross Profit2.83B
Operating Income842.60M
Pretax Income1.15B
Net Income840.05M
EBITDA1.00B
Earnings Per Share (EPS)1.11
Cash Flow
In the last 12 months, operating cash flow was 564.12M and capital expenditures -74.50M, giving a free cash flow of 489.62M billion.
Operating Cash Flow564.12M
Free Cash Flow489.62M
Free Cash Flow per Share0.59
Dividends & Yields
China Shineway Pharmaceutical Group Limited pays an annual dividend of HK$0.384, resulting in a dividend yield of 8.14%
Dividend Per ShareHK$0.384
Dividend Yield8.14%
Payout Ratio9.86%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.58
52-Week Price Change-19.19%
50-Day Moving Average7.69
200-Day Moving Average8.10
Relative Strength Index (RSI)40.79
Average Volume (3m)1.24M
Important Dates
China Shineway Pharmaceutical Group Limited upcoming earnings date is Sep 2, 2025, TBA Not Confirmed.
Last Earnings DateMar 28, 2025
Next Earnings DateSep 2, 2025
Ex-Dividend DateApr 30, 2025
Financial Position
China Shineway Pharmaceutical Group Limited as a current ratio of 3.51, with Debt / Equity ratio of 4.64%
Current Ratio3.51
Quick Ratio3.18
Debt to Market Cap0.05
Net Debt to EBITDA-5.78
Interest Coverage Ratio137.48
Taxes
In the past 12 months, China Shineway Pharmaceutical Group Limited has paid 305.67M in taxes.
Income Tax305.67M
Effective Tax Rate0.27
Enterprise Valuation
China Shineway Pharmaceutical Group Limited EV to EBITDA ratio is 1.06, with an EV/FCF ratio of 1.29.
EV to Sales0.28
EV to EBITDA1.06
EV to Free Cash Flow1.29
EV to Operating Cash Flow1.11
Balance Sheet
China Shineway Pharmaceutical Group Limited has HK$6.49B in cash and marketable securities with ¥346.53M in debt, giving a net cash position of -HK$6.14B billion.
Cash & Marketable SecuritiesHK$6.49B
Total Debt¥346.53M
Net Cash-HK$6.14B
Net Cash Per Share-HK$7.43
Tangible Book Value Per ShareHK$9.62
Margins
Gross margin is 74.95%, with operating margin of 22.30%, and net profit margin of 22.24%.
Gross Margin74.95%
Operating Margin22.30%
Pretax Margin30.33%
Net Profit Margin22.24%
EBITDA Margin26.52%
EBIT Margin22.13%
Analyst Forecast
The average price target for China Shineway Pharmaceutical Group Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-18.09%
EPS Growth Forecast-15.08%